Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nishank Jain

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Kidney International Reports|February 5, 2024
Updates on New Therapies for Patients with CKDTushar Tarun, Sai Nikhila Ghanta, Vincz Ong, et al.
Journal of the American Heart Association|July 7, 2017
Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With OutcomesL Parker Gregg, Beverley Adams-Huet, Xilong Li, et al.
American Journal of Nephrology|June 6, 2019
Fatigue in Nondialysis Chronic Kidney Disease: Correlates and Association with Kidney OutcomesL Parker Gregg, Nishank Jain, Thomas Carmody, et al.
Kidney International|May 31, 2024
Platelets, inflammation, and purinergic receptors in chronic kidney diseaseAdam L Corken, Vincz Ong, Rajshekhar Kore, et al.
Contemporary Clinical Trials|October 23, 2012
Rationale and design of the Chronic Kidney Disease Antidepressant Sertraline Trial (CAST)Nishank Jain, Madhukar H Trivedi, A John Rush, et al.
Journal of the American Society of Nephrology : JASN|September 7, 2023
Platelet Count and Platelet Volume in Patients with CKDOtis M Davis, Rajshekhar Kore, Alexandra Moore, et al.
JAMA|November 5, 2017
Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical TrialS Susan Hedayati, L Parker Gregg, Thomas Carmody, et al.
Cardiovascular Drugs and Therapy|November 16, 2019
Trends for and Clinical Factors Associated with Choice of Oral P2Y<sub>12</sub> Inhibitors for Patients on Chronic DialysisNishank Jain, Suzanne L Hunt, Huizhong Cui, et al.
Kidney360|September 30, 2022
Age Modifies Intracranial and Gastrointestinal Bleeding Risk from P2Y<sub>12</sub> Inhibitors in Patients Receiving DialysisNishank Jain, Bradley C Martin, Junqiang Dai, et al.
Kidney International Reports|September 13, 2021
Comparative Effectiveness and Safety of Oral P2Y12 Inhibitors in Patients on Chronic DialysisNishank Jain, Milind A Phadnis, Suzanne L Hunt, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Kidney International Reports|February 5, 2024
Updates on New Therapies for Patients with CKDTushar Tarun, Sai Nikhila Ghanta, Vincz Ong, et al.
Journal of the American Heart Association|July 7, 2017
Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With OutcomesL Parker Gregg, Beverley Adams-Huet, Xilong Li, et al.
American Journal of Nephrology|June 6, 2019
Fatigue in Nondialysis Chronic Kidney Disease: Correlates and Association with Kidney OutcomesL Parker Gregg, Nishank Jain, Thomas Carmody, et al.
Kidney International|May 31, 2024
Platelets, inflammation, and purinergic receptors in chronic kidney diseaseAdam L Corken, Vincz Ong, Rajshekhar Kore, et al.
Contemporary Clinical Trials|October 23, 2012
Rationale and design of the Chronic Kidney Disease Antidepressant Sertraline Trial (CAST)Nishank Jain, Madhukar H Trivedi, A John Rush, et al.
Journal of the American Society of Nephrology : JASN|September 7, 2023
Platelet Count and Platelet Volume in Patients with CKDOtis M Davis, Rajshekhar Kore, Alexandra Moore, et al.
JAMA|November 5, 2017
Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical TrialS Susan Hedayati, L Parker Gregg, Thomas Carmody, et al.
Cardiovascular Drugs and Therapy|November 16, 2019
Trends for and Clinical Factors Associated with Choice of Oral P2Y<sub>12</sub> Inhibitors for Patients on Chronic DialysisNishank Jain, Suzanne L Hunt, Huizhong Cui, et al.
Kidney360|September 30, 2022
Age Modifies Intracranial and Gastrointestinal Bleeding Risk from P2Y<sub>12</sub> Inhibitors in Patients Receiving DialysisNishank Jain, Bradley C Martin, Junqiang Dai, et al.
Kidney International Reports|September 13, 2021
Comparative Effectiveness and Safety of Oral P2Y12 Inhibitors in Patients on Chronic DialysisNishank Jain, Milind A Phadnis, Suzanne L Hunt, et al.
Pageof 5